Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Circulating Markers of Inflammation Persist in Children and Adults With Giant Aneurysms After Kawasaki Disease.

Lech M, Guess J, Duffner J, Oyamada J, Shimizu C, Hoshino S, Farutin V, Bulik DA, Gutierrez B, Sarvaiya H, Kapoor B, Koppes L, Saldova R, Stockmann H, Albrecht S, McManus C, Rudd PM, Kaundinya GV, Manning AM, Bosques CJ, Kahn AM, Daniels LB, Gordon JB, Tremoulet AH, Capila I, Gunay NS, Ling LE, Burns JC.

Circ Genom Precis Med. 2019 Apr;12(4):e002433. doi: 10.1161/CIRCGEN.118.002433. Epub 2019 Mar 7.

PMID:
30844302
2.

Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity.

Reeves EP, Dunlea DM, McQuillan K, O'Dwyer CA, Carroll TP, Saldova R, Akepati PR, Wormald MR, McElvaney OJ, Shutchaidat V, Henry M, Meleady P, Keenan J, Liberti DC, Kotton DN, Rudd PM, Wilson AA, McElvaney NG.

J Immunol. 2019 Apr 15;202(8):2240-2253. doi: 10.4049/jimmunol.1801045. Epub 2019 Feb 22.

3.

Resident bacteria in breast cancer tissue: pathogenic agents or harmless commensals?

O'Connor H, MacSharry J, Bueso YF, Lindsay S, Kavanagh EL, Tangney M, Clyne M, Saldova R, McCann A.

Discov Med. 2018 Sep;26(142):93-102. Review.

4.

Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer.

Murphy K, Murphy BT, Boyce S, Flynn L, Gilgunn S, O'Rourke CJ, Rooney C, Stöckmann H, Walsh AL, Finn S, O'Kennedy RJ, O'Leary J, Pennington SR, Perry AS, Rudd PM, Saldova R, Sheils O, Shields DC, Watson RW.

Mol Oncol. 2018 Sep;12(9):1513-1525. doi: 10.1002/1878-0261.12348. Epub 2018 Aug 7.

5.

N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome.

Terkelsen T, Haakensen VD, Saldova R, Gromov P, Hansen MK, Stöckmann H, Lingjaerde OC, Børresen-Dale AL, Papaleo E, Helland Å, Rudd PM, Gromova I.

Mol Oncol. 2018 Jun;12(6):972-990. doi: 10.1002/1878-0261.12312. Epub 2018 May 14.

6.

Expression, Purification, and Biochemical Characterization of Human Afamin.

Altamirano A, Naschberger A, Fürnrohr BG, Saldova R, Struwe WB, Jennings PM, Millán Martín S, Malic S, Plangger I, Lechner S, Pisano R, Peretti N, Linke B, Aguiar MM, Fresser F, Ritsch A, Lenac Rovis T, Goode C, Rudd PM, Scheffzek K, Rupp B, Dieplinger H.

J Proteome Res. 2018 Mar 2;17(3):1269-1277. doi: 10.1021/acs.jproteome.7b00867. Epub 2018 Feb 20.

PMID:
29441788
7.

Erratum: Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes: Erratum.

Llop E, Ferrer-Batallé M, Barrabés S, Guerrero PE, Ramírez M, Saldova R, Rudd PM, Aleixandre RN, Comet J, de Llorens R, Peracaula R.

Theranostics. 2018 Jan 1;8(3):746-748. doi: 10.7150/thno.23906. eCollection 2018.

8.

Glycosylation Repurposes Alpha-1 Antitrypsin for Resolution of Community-acquired Pneumonia.

McCarthy C, Dunlea DM, Saldova R, Henry M, Meleady P, McElvaney OJ, Marsh B, Rudd PM, Reeves EP, McElvaney NG.

Am J Respir Crit Care Med. 2018 May 15;197(10):1346-1349. doi: 10.1164/rccm.201709-1954LE. No abstract available.

PMID:
29144158
9.

Serum N-glycome alterations in breast cancer during multimodal treatment and follow-up.

Saldova R, Haakensen VD, Rødland E, Walsh I, Stöckmann H, Engebraaten O, Børresen-Dale AL, Rudd PM.

Mol Oncol. 2017 Oct;11(10):1361-1379. doi: 10.1002/1878-0261.12105. Epub 2017 Jul 24.

10.

Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy.

Mimura Y, Katoh T, Saldova R, O'Flaherty R, Izumi T, Mimura-Kimura Y, Utsunomiya T, Mizukami Y, Yamamoto K, Matsumoto T, Rudd PM.

Protein Cell. 2018 Jan;9(1):47-62. doi: 10.1007/s13238-017-0433-3. Epub 2017 Jun 8. Review.

11.

Advances in analytical methodologies to guide bioprocess engineering for bio-therapeutics.

Saldova R, Kilcoyne M, Stöckmann H, Millán Martín S, Lewis AM, Tuite CM, Gerlach JQ, Le Berre M, Borys MC, Li ZJ, Abu-Absi NR, Leister K, Joshi L, Rudd PM.

Methods. 2017 Mar 1;116:63-83. doi: 10.1016/j.ymeth.2016.11.002. Epub 2016 Nov 8.

PMID:
27832969
12.
13.

Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.

Greville G, McCann A, Rudd PM, Saldova R.

Epigenetics. 2016 Dec;11(12):845-857. Epub 2016 Sep 30. Review.

14.

Comprehensive N-Glycan Profiling of Avian Immunoglobulin Y.

Gilgunn S, Millán Martín S, Wormald MR, Zapatero-Rodríguez J, Conroy PJ, O'Kennedy RJ, Rudd PM, Saldova R.

PLoS One. 2016 Jul 26;11(7):e0159859. doi: 10.1371/journal.pone.0159859. eCollection 2016.

15.

Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.

Llop E, Ferrer-Batallé M, Barrabés S, Guerrero PE, Ramírez M, Saldova R, Rudd PM, Aleixandre RN, Comet J, de Llorens R, Peracaula R.

Theranostics. 2016 May 24;6(8):1190-204. doi: 10.7150/thno.15226. eCollection 2016. Erratum in: Theranostics. 2018 Jan 1;8(3):746-748.

16.

Serum N-Glycome Characterization in Patients with Resectable Periampullary Adenocarcinoma.

Hamfjord J, Saldova R, Stöckmann H, Sandhu V, Bowitz Lothe IM, Buanes T, Lingjærde OC, Labori KJ, Rudd PM, Kure EH.

J Proteome Res. 2015 Dec 4;14(12):5144-56. doi: 10.1021/acs.jproteome.5b00395. Epub 2015 Nov 17.

PMID:
26515733
17.

N-Glycosylation of Serum IgG and Total Glycoproteins in MAN1B1 Deficiency.

Saldova R, Stöckmann H, O'Flaherty R, Lefeber DJ, Jaeken J, Rudd PM.

J Proteome Res. 2015 Oct 2;14(10):4402-12. doi: 10.1021/acs.jproteome.5b00709. Epub 2015 Sep 24.

PMID:
26401844
18.

Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome.

Haakensen VD, Steinfeld I, Saldova R, Shehni AA, Kifer I, Naume B, Rudd PM, Børresen-Dale AL, Yakhini Z.

Mol Oncol. 2016 Jan;10(1):59-72. doi: 10.1016/j.molonc.2015.08.002. Epub 2015 Aug 19.

19.

Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin.

Balmaña M, Sarrats A, Llop E, Barrabés S, Saldova R, Ferri MJ, Figueras J, Fort E, de Llorens R, Rudd PM, Peracaula R.

Clin Chim Acta. 2015 Mar 10;442:56-62. doi: 10.1016/j.cca.2015.01.007. Epub 2015 Jan 14.

PMID:
25595436
20.

Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.

Vandooren J, Born B, Solomonov I, Zajac E, Saldova R, Senske M, Ugarte-Berzal E, Martens E, Van den Steen PE, Van Damme J, Garcia-Pardo A, Froeyen M, Deryugina EI, Quigley JP, Moestrup SK, Rudd PM, Sagi I, Opdenakker G.

Biochem J. 2015 Jan 15;465(2):259-70. doi: 10.1042/BJ20140418.

Supplemental Content

Loading ...
Support Center